#regenxbio

2 briefings

FDA Reverses Course Again, Clearing Regenxbio to Resubmit Gene Therapy

Jun 22, 2026, 7:48 PM

Regenxbio Will Resubmit Hunter Syndrome Gene Therapy to FDA — No New Study Required

Jun 22, 2026, 3:22 PM